Adicet Bio (ACET) Profit After Tax (2017 - 2026)

Adicet Bio's Profit After Tax history runs 10 years deep, the most recent figure standing at -$20.4 million for Q1 2026.

• In Q1 2026, Profit After Tax rose 27.76% year-over-year to -$20.4 million; the TTM figure through Mar 2026 stood at -$108.9 million (up 7.19% YoY), while the FY2025 annual figure was -$116.7 million, changed 0.35% from the prior year.
• Profit After Tax for Q1 2026 stood at -$20.4 million, up from -$30.4 million in the prior quarter.
• The five-year high for Profit After Tax was $4.6 million in Q1 2022, with the low at -$49.9 million in Q3 2023.
• The 5-year median for Profit After Tax is -$29.5 million (2023), against an average of -$27.5 million.
• The sharpest annual moves came in 2022 and 2023: Profit After Tax jumped 121.66% in 2022, then sank 768.71% in 2023.
• Adicet Bio's Profit After Tax stood at -$29.9 million in 2022, then increased by 1.29% to -$29.5 million in 2023, then climbed by 2.17% to -$28.8 million in 2024, then slipped by 5.48% to -$30.4 million in 2025, then surged by 33.02% to -$20.4 million in 2026.
• Business Quant data shows ACET's Profit After Tax at -$20.4 million in Q1 2026, -$30.4 million in Q4 2025, and -$26.9 million in Q3 2025.